Cite
HARVARD Citation
Ylescas‐Soria, J. et al. (n.d.). Prognostic factors for overall survival in patients with chronic myeloid leukemia treated with imatinib at the National Cancer Institute – Mexico, from 2000 to 2016. Cancer medicine. pp. 2942-2949. [Online].